Our News on Newswise

SHRO’s Giordano Climbs the Ranks of Top Scientists List

Sbarro Health Research Organization (SHRO) Founder and Director, the Italian American Antonio Giordano, MD, PhD, climbs in the rankings of the top scientists in the United States and around the world. This recognition puts Giordano in the company of...
17-Jun-2024 7:05 AM EDT Add to Favorites

Virtual Reality Supports Pregnant Patients in the Delivery Room

The pain of labor and childbirth may be reduced through the use of a Virtual Reality (VR) relaxation program timed with contractions.
14-Jun-2024 1:05 PM EDT Add to Favorites

Newswise: 66505dd026335_image01.jpeg

From Bench to Bedside on Ovarian Cancer

May 22nd marked a significant milestone in the collaborative efforts to combat ovarian cancer as the "International Dialogue on Ovarian Cancer, from Bench to Bedside" congress was held, bridging the gap between primary research and clinical practice.
23-May-2024 7:05 PM EDT Add to Favorites

Gene Expression and Bioinformatics Tools to Optimize Cancer Therapy

In the field of biomedical research and genomics, the advancement of bioinformatics technologies and tools is opening new frontiers in the understanding of diseases and their diagnosis and treatment.
2-May-2024 9:05 PM EDT Add to Favorites

Newswise: 6608ceece02ef_PHOTO-2024-03-29-06-51-551.jpg

Golden Lion Award For Lifetime Achievement Presented to the Italian-American Scientist Antonio Giordano

Award recognizes Giordano for Italian Scientific Excellence in the world and the International Study on the correlation between health and pollution in the Land of Fire in Campania
30-Mar-2024 10:05 PM EDT Add to Favorites

Newswise: 660476461028c_image0.jpeg

Italians Abroad Can Easily Resume Healthcare Coverage When Returning to Italy

Italians residing abroad and registered with the EU health card service are guaranteed the maintenance of medical assistance and health exemptions when they return to Italy.
27-Mar-2024 3:05 PM EDT Add to Favorites

Mesothelioma Protein Identified With Cancer Inhibiting Effect

Malignant mesothelioma is a very aggressive cancer with a very poor survival and limited treatment options. Thus, a deeper knowledge of the mechanisms modulating mesothelioma initiation and progression is critical for novel therapeutic strategies.
21-Mar-2024 12:05 PM EDT Add to Favorites

Newswise: 65fd75b535444_PHOTO-2024-03-21-13-24-42.jpg

SHRO and Temple Create iNest to Commercialize Innovations

With funding from the Commonwealth of Pennsylvania and the Sbarro Health Research Organization (SHRO), the latest incubator and technology transfer institute opens at Temple University.
18-Mar-2024 9:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert

COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST

Newswise: Slide1.jpg

Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT

Newswise: giordanoheadshot.png

Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST

See All Experts

About

Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.

Experts

Contacts

Barbara Colombo

barbaracolombo@ble-group.com

Antonio Giordano
President

president@shro.org

215-204-9520

James Vincenzo
Billing

jvincenzo@shro.org

Twitter

close
0.41133